英文名稱 | Idarubicinone(Idarubicin Aglycone); (7S,9S)-9-Acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione |
---|---|
中文名稱 | 伊達比星酮; (7S,9S)9-乙?;?7,8,9,10-四氫-6,7,9,11-四羥基-5,12-并四苯二酮 |
CAS號 | 60660-75-5 |
分子式 | C20H16O7 |
分子量 | 368.34 |
MDL | MFCD09952466 |
英文名稱 | Idarubicinone(Idarubicin Aglycone); (7S,9S)-9-Acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione |
---|---|
中文名稱 | 伊達比星酮; (7S,9S)9-乙?;?7,8,9,10-四氫-6,7,9,11-四羥基-5,12-并四苯二酮 |
CAS號 | 60660-75-5 |
分子式 | C20H16O7 |
分子量 | 368.34 |
MDL | MFCD09952466 |
Idarubicin Aglycone (CAS No: 60660-75-5) Or (7S,9S)-9-acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione, Idarubicin is an anthracycline antineoplastic agent, which is used to treat acute myeloid leukemia, breast cancer, reduced cardiac toxicity by inhibits topoisomerase II activity and it has antimitotic and cytotoxic activity.